JP2016516801A5 - - Google Patents

Download PDF

Info

Publication number
JP2016516801A5
JP2016516801A5 JP2016508193A JP2016508193A JP2016516801A5 JP 2016516801 A5 JP2016516801 A5 JP 2016516801A5 JP 2016508193 A JP2016508193 A JP 2016508193A JP 2016508193 A JP2016508193 A JP 2016508193A JP 2016516801 A5 JP2016516801 A5 JP 2016516801A5
Authority
JP
Japan
Prior art keywords
composition
infections
set composition
oil
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016508193A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016516801A (ja
JP6321781B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/058162 external-priority patent/WO2014170505A2/en
Publication of JP2016516801A publication Critical patent/JP2016516801A/ja
Publication of JP2016516801A5 publication Critical patent/JP2016516801A5/ja
Application granted granted Critical
Publication of JP6321781B2 publication Critical patent/JP6321781B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016508193A 2013-04-19 2014-04-22 免疫微量栄養 Expired - Fee Related JP6321781B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP13164434.6 2013-04-19
EP13164434 2013-04-19
EP13197725 2013-12-17
EP13197725.8 2013-12-17
PCT/EP2014/058162 WO2014170505A2 (en) 2013-04-19 2014-04-22 Immunity micronutrition

Publications (3)

Publication Number Publication Date
JP2016516801A JP2016516801A (ja) 2016-06-09
JP2016516801A5 true JP2016516801A5 (enExample) 2017-06-08
JP6321781B2 JP6321781B2 (ja) 2018-05-09

Family

ID=51022289

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016508193A Expired - Fee Related JP6321781B2 (ja) 2013-04-19 2014-04-22 免疫微量栄養

Country Status (11)

Country Link
US (1) US20160095879A1 (enExample)
EP (1) EP3027056B1 (enExample)
JP (1) JP6321781B2 (enExample)
CN (1) CN105555150A (enExample)
AP (1) AP2015008861A0 (enExample)
AU (1) AU2014255617B2 (enExample)
EA (1) EA029476B1 (enExample)
IL (1) IL242072B (enExample)
SG (2) SG11201508640SA (enExample)
WO (1) WO2014170505A2 (enExample)
ZA (1) ZA201508547B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3026643B1 (fr) * 2014-10-02 2018-03-09 Biodevas Laboratoires Aliment complementaire a base d'extraits de plantes aromatiques pour la gestion de la dermatite digitee ou mortellaro par la gestion du stress abiotique
CN106236787A (zh) * 2016-08-30 2016-12-21 青海民族大学 圆孢蘑菇抗hiv‑1病毒有效部位及制法和应用
RS20171030A1 (sr) 2017-10-12 2019-04-30 Pavlovic Bojan F-fukoidani, desulfonovani f-fukoidani i njihovi derivati, desulfonovane oligo-fukoze kao inhibitori gastrointestinalnih infekcija
IT201700115753A1 (it) * 2017-10-13 2019-04-13 Cristalfarma S R L Integratore per attenuare i disturbi nella donna causati dall’invecchiamento
GB2578417B (en) * 2018-06-11 2022-09-28 Hunt Dev Uk Ltd Airway sampling device and associated methods
US20230148646A1 (en) * 2020-04-24 2023-05-18 Patrick Todorov ANGELOV Anti-viral, anti-microbial and stimulating immunity food supplement
US20210386779A1 (en) * 2020-04-30 2021-12-16 Leon Margolin Compositions and methods for dietary enhancement of immune system function
EP4014759A1 (en) * 2020-12-18 2022-06-22 VIRAofSWEDEN AB Novel product comprising brown alga extract
US20230149493A1 (en) * 2021-06-08 2023-05-18 Yuva Biosciences, Inc. Compositions and methods for treating covid-19 and symptoms thereof
TR2022000292A2 (tr) 2022-01-11 2022-02-21 Tuerkiye Bilimsel Veteknolojik Arastirma Kurumu SARS-CoV-2 Virüsüne Karşı Koruyucu Pastil/Çiğneme Tableti Üretimi
GR1010704B (el) * 2023-04-11 2024-06-03 Ιουλια Κλεωνος Τσετη Συνθεση για την ομαλοποιηση των λειτουργιων του ανοσοποιητικου συστηματος και τη φυσικη καθαρση του ιου hpv (human papilloma virus)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040146545A1 (en) * 1999-05-19 2004-07-29 Elisabeth Caenazzo Method for making products used in sequential micronutrition and uses of resulting products
CN1829453A (zh) * 2003-06-04 2006-09-06 威廉·雅各布·塞尔方丹 营养组合物及其用途
EP1643865A1 (en) * 2003-06-04 2006-04-12 Willem Jacob Serfontein Nutritional compositions and use thereof
US20080038367A1 (en) * 2006-08-11 2008-02-14 Sal Saloum Nutritional supplement compositions and methods of preparing
RU2010132283A (ru) * 2008-02-06 2012-03-20 Дзе Проктер Энд Гэмбл Компани (US) Композиции, способы и наборы для повышения иммунного ответа на респираторное заболевание
JP2009221112A (ja) * 2008-03-13 2009-10-01 Unitec Foods Co Ltd 免疫機能調節組成物
US8518459B2 (en) * 2009-04-15 2013-08-27 Actigenomics S.A. Composition for regulating lipid metabolism
KR20110121088A (ko) * 2010-04-30 2011-11-07 주식회사 엔케이바이오 치료 후 손상된 세포조직의 재생과 성장 및 체내 면역력을 증가시켜주는 2차 감염 방지용 면역강화 조성물

Similar Documents

Publication Publication Date Title
JP2016516801A5 (enExample)
Wang et al. The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb
JP6321781B2 (ja) 免疫微量栄養
JP2012072157A5 (enExample)
HK1221646A1 (zh) 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途
HK1206246A1 (en) Use of high dose laquinimod for treating multiple sclerosis
NZ745678A (en) Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
MX2017004592A (es) Formulaciones farmaceuticas para la administracion oral de farmacos peptidicos o proteinicos.
HRP20141258T1 (hr) 6-amino-2-{[(1s)-1-metilbutil]oksi}-9-[5-(1-piperidinil)pentil]-7,9-dihidro-8h-purin-8-on maleat
WO2017083304A8 (en) Therapeutic compositions for treatment of human immunodeficiency virus
BR112016021985A8 (pt) formulação farmacêutica e composto
WO2015020943A3 (en) Digestive enzyme composition suitable for enteral administration
WO2012098562A3 (en) Liquid oral compositions of lanthanum salts
EP3590498A4 (en) PREPARATION WITH INCLUDING COMPLEX OF VARENICLINE OR PHARMACEUTICAL SAFE SALT THEREOF FOR ORAL ADMINISTRATION
EP3400964A4 (en) TASTE-MASKED AND ORAL ADMINISTRATIVE PHARMACEUTICAL PREPARATION WITH VARENICLIN OR PHARMACEUTICAL SALT OF IT
JP2017507142A5 (enExample)
RU2016145066A (ru) Композиция для предотвращения или лечения жировых болезней печени
RU2019110980A (ru) Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением
HK1225972A1 (zh) 利用拉喹莫德来延缓亨廷顿氏病的进展
JP2017061488A5 (enExample)
JP2015533484A5 (enExample)
HK1245095A1 (zh) 依维莫司(everolimus)与达托里昔布(dactolisib)的医药组合
WO2015165964A8 (en) Treatment and prevention of alzheimer's disease (ad)
WO2018078599A3 (en) Composition for the preventive or curative treatment of liver disorders
MY187270A (en) Renal insufficiency progression inhibitor, prophylactic agent for renal insufficiency and indoxyl sulfate production inhibitor